Table 5.

Relative risk (RR) (95 % CI) for clinical parameters in patient with coinfections compared to patients without coinfections

	% (n)	% (n)	RR (95% CI)	p
Co-Infections
D-Dimer	<4 μg/ml	≥4 μg/ml
None	66.7 (8)	33.3 (4)	1
Other	81.8 (9)	18.2 (2)	0.5 (0.1–2.4)	0.64
MSSA/MRSA	14.3 (1)	85.7 (6)	2.6 (1.1–6.0)	0.057
INR	Ratio <1.5	Ratio ≥1.5
None	75.0 (9)	25.0 (3)	1
Other	81.8 (9)	18.2 (2)	0.7 (0.1–3.6)	1.00
MSSA/MRSA	37.5 (3)	62.5 (5)	2.5 (0.8–7.6)	0.17
PRISM III	Score <10	Score ≥10
None	71.9 (23)	28.1 (9)	1
Other	72.7 (16)	27.3 (6)	1.0 (0.4–2.3)	1.00
MRSA/MSSA	33.3 (4)	66.7 (8)	2.4 (1.2–4.7)	0.035
DIC	No	Yes
None	90.6 (29)	9.4 (3)	1
Other	95.5 (21)	4.5 (1)	0.5 (0.05–4.4)	0.64
MSSA/MRSA	58.3 (7)	41.7 (5)	4.4 (1.3–15.8)	0.025

MSSA/MRSA, Methicillin-sensitive/resistant Staphylococcus aureus; INR, international normalized ratio; PRISM, Pediatric Risk of Mortality; DIC, disseminated intravascular coagulation; Fisher exact test; RR, relative risk; CI, confidence interval; INR, international normalized ratio; DIC disseminated intravascular coagulation